4.6 Editorial Material

AD Hypotheses and Suggested Clinical Trials

Journal

ACS CHEMICAL NEUROSCIENCE
Volume 12, Issue 21, Pages 3968-3971

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/acschemneuro.1c00627

Keywords

Alzheimer's disease; cognitive reserve; neurodegenerative diseases; neurofibrillary tangles; oxidative stress; antioxidants; glutathione; A beta peptide

Ask authors/readers for more resources

Alzheimer's disease is a major neurodegenerative disorder characterized by the deposition of hyperphosphorylated tau proteins and amyloid-beta, with oxidative stress being a vital factor in its pathogenesis. Antioxidative therapeutic interventions are at the forefront of AD research, suggesting a potential future treatment avenue for the disease.
Alzheimer's disease (AD) is a major neurodegenerative disorder that impairs cognitive reserve impacting activities of daily living. The prime pathological characteristics of AD include the deposition of neurofibrillary tangles of hyperphosphorylated tau (t) proteins, accumulation of amyloid-beta (A beta), and neuronal loss. Expanding literature suggests that oxidative stress (OS) is a vital factor contributing to the pathogenesis of AD such that biometals (e.g., iron, zinc, copper) are believed to play a crucial role in A beta formation and neurodegeneration. Growing evidence indicates the impact of OS in AD, and clinical trials with antioxidative therapeutic interventions are in the frontline of AD research. We discuss various AD hypotheses and associated clinical trials. We present a case for future therapeutic intervention for AD by putting forth postulated hypotheses and trials.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available